Francesc Palau Selected Research

Frataxin

1/2022	Frataxin Deficit Leads to Reduced Dynamics of Growth Cones in Dorsal Root Ganglia Neurons of Friedreich's Ataxia YG8sR Model: A Multilinear Algebra Approach.
1/2020	Cofilin dysregulation alters actin turnover in frataxin-deficient neurons.
1/2019	Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.
1/2016	Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich's ataxia.
1/2014	Mitochondrial dysfunction induced by frataxin deficiency is associated with cellular senescence and abnormal calcium metabolism.
1/2011	Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts.
1/2010	Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.
1/2009	Friedreich ataxia: an update on animal models, frataxin function and therapies.
11/2006	Autosomal recessive cerebellar ataxias.
1/2006	Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesc Palau Research Topics

Disease

12	Friedreich Ataxia (Friedreich's Ataxia) 01/2022 - 08/2005
6	Type 4A Charcot-Marie-Tooth disease 04/2015 - 01/2004
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2009
5	Neuroblastoma 11/2021 - 04/2005
5	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2015 - 01/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2010 - 08/2005
3	Coenzyme Q10 Deficiency 02/2024 - 07/2006
3	Rare Diseases (Rare Disease) 01/2022 - 01/2011
3	Neuromuscular Diseases (Neuromuscular Disease) 04/2021 - 11/2013
3	Ataxia (Dyssynergia) 07/2010 - 11/2006
2	Parkinson Disease (Parkinson's Disease) 10/2021 - 01/2009
2	Cerebellar Ataxia (Dysmetria) 01/2019 - 07/2006
2	Type 2K Charcot-Marie-Tooth disease 04/2015 - 12/2010
2	Ataxia with vitamin E deficiency 09/2008 - 11/2006
1	Hearing Loss (Hearing Impairment) 03/2024
1	Muscular Diseases (Myopathy) 03/2024
1	Malformed Nails (Pachyonychia) 03/2024
1	Rigor Mortis 02/2024
1	Muscular Dystrophies (Muscular Dystrophy) 01/2023
1	Rhabdomyolysis 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2022
1	Starvation 01/2022
1	Megalencephaly 01/2022
1	Airway Obstruction (Choking) 01/2022
1	Neurodevelopmental Disorders 01/2022
1	Weight Gain 11/2021
1	Menkes Kinky Hair Syndrome (Menkes Disease) 01/2021
1	Occipital horn syndrome 01/2021
1	Epilepsy (Aura) 01/2020
1	Hartnup Disease 12/2019
1	Tics (Tic) 12/2019
1	Kearns-Sayre Syndrome 11/2018
1	Celiac Disease (Celiac Sprue) 01/2018
1	Inflammation (Inflammations) 01/2017
1	Carcinogenesis 01/2015
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2013
1	X-Linked Genetic Diseases 11/2013
1	Glutathione synthetase deficiency 01/2013
1	Metabolic Diseases (Metabolic Disease) 08/2012
1	sideroblastic spinocerebellar ataxia Anemia 06/2011
1	Tomaculous neuropathy 06/2010
1	Type 4C Charcot-Marie-Tooth disease 12/2009
1	Hereditary Spastic Paraplegia 01/2009
1	Paralysis (Palsy) 11/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2008
1	autosomal recessive 1 Spinocerebellar ataxia 11/2006

Drug/Important Bio-Agent (IBA)

11	FrataxinIBA 01/2022 - 08/2005
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2005
5	CalciumIBA 01/2022 - 08/2013
4	coenzyme Q10 (CoQ10)IBA 02/2024 - 07/2006
4	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022 - 01/2006
3	GDAP proteinIBA 12/2010 - 09/2003
2	Dopamine (Intropin)FDA LinkGeneric 10/2021 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2014
2	alpha-tocopherol transfer proteinIBA 09/2008 - 11/2006
2	GangliosidesIBA 02/2006 - 01/2004
1	Mitogen-Activated Protein KinasesIBA 03/2024
1	dystrobrevinIBA 01/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	Protein SIBA 06/2022
1	Fetal Hemoglobin (Hemoglobin F)IBA 01/2022
1	LipidsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2021
1	AntioxidantsIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	florfenicolIBA 11/2021
1	mitoquinoneIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 04/2021
1	Copper Transport ProteinsIBA 01/2021
1	Carisoprodol (Soma)FDA LinkGeneric 01/2021
1	Laminin (Merosin)IBA 01/2020
1	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2019
1	Phosphodiesterase InhibitorsIBA 01/2019
1	PterinsIBA 11/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2018
1	Biogenic Amines (Biogenic Amine)IBA 11/2018
1	Mitochondrial DNA (mtDNA)IBA 11/2018
1	Membrane LipidsIBA 01/2017
1	Histones (Histone)IBA 01/2015
1	junctophilinIBA 01/2015
1	DystrophinIBA 11/2013
1	Glutathione (Reduced Glutathione)IBA 01/2013
1	Glutathione Synthase (Glutathione Synthetase)IBA 01/2013
1	Pyroglutamate Hydrolase (5 Oxoprolinase)IBA 01/2013
1	EnzymesIBA 01/2013
1	Complement System Proteins (Complement)IBA 08/2012
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2011
1	UbiquinoneIBA 07/2010
1	Coenzymes (Enzyme Cofactors)IBA 07/2010
1	Myelin ProteinsIBA 06/2010
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2010
1	IronIBA 01/2009
1	ApolipoproteinsIBA 09/2008
1	Vitamin E FDA LinkGeneric 09/2008
1	A-Form DNA (A-DNA)IBA 11/2006
1	4-hydroxybenzoic acid (p-hydroxybenzoate)IBA 07/2006

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2009
1	Aftercare (After-Treatment) 02/2024
1	Operative Surgical Procedures 01/2022
1	Precision Medicine 03/2012